EXPRESSION OF THE RETINOBLASTOMA GENE-PRODUCT IN CLINICAL THYROID TISSUES - A REASON FOR THE SLOW GROWTH OF THYROID-CARCINOMA

Citation
Y. Ito et al., EXPRESSION OF THE RETINOBLASTOMA GENE-PRODUCT IN CLINICAL THYROID TISSUES - A REASON FOR THE SLOW GROWTH OF THYROID-CARCINOMA, Oncology Reports, 3(1), 1996, pp. 57-62
Citations number
37
Categorie Soggetti
Oncology
Journal title
ISSN journal
1021335X
Volume
3
Issue
1
Year of publication
1996
Pages
57 - 62
Database
ISI
SICI code
1021-335X(1996)3:1<57:EOTRGI>2.0.ZU;2-A
Abstract
We investigated the expression of the retinoblastoma gene product (pRB ) in various clinical thyroid tissues. Follicular cells in the normal thyroid sometimes expressed pRB but their positive cell ratio was alwa ys less than 10% as it was in hyperplasia. All of the 57 carcinomas te sted expressed pRB immunohistochemically with various positivity and 3 6 of them (63.2%) showed high immunoreactivity. In contrast, only four of the 15 follicular adenoma samples (26.7%) revealed moderate pRB im munoreactivity and there was a statistically significant difference (p <0.01) in PRE positivity between the carcinomas, including follicular ones, and benign follicular adenomas. These findings indicate that pRB may be closely related to the suppression of tumoral growth, especial ly of carcinoma growth of the thyroid. Western blot analysis showed pR B immunoreactivity for all tested samples to be a single, sharp band l ocated at 110 kDa, indicating that pRB in thyroid tumors is always unp hosphorylated and active. The present study suggests that frequent pRB expression in an active form could be one of the reasons for the slow growth and excellent prognosis of thyroid carcinoma.